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Abstract
Using [1H,15N] heteronuclear single quantum coherance (HSQC) NMR and 15N-labeled carboplatin, 1, we show that Jurkat cells
aﬀect the rate of disappearance of the HSQC NMR peak in culture medium for this Pt2+ anticancer drug. The decay or disappearance
rate constant for 1 in culture medium containing cells is k 1 ¼ k c ½CO2
3  þ k m þ k u N , where kc is the rate constant for reaction of 1 with
carbonate in the medium, km is the rate constant for reaction of 1 with all other components of the medium, and ku is the rate constant
for reaction of 1 with cells having a number density N in the medium. Since Jurkat cells only take up a small amount of the platinum
present in the medium (<1%), the observed disappearance of the HSQC NMR peak for 1 cannot be due to uptake of carboplatin by the
cells.
 2007 Elsevier Inc. All rights reserved.
Keywords: Pt complex; Cells; NMR

1. Introduction
Carboplatin, [Pt(NH3)2(CBDCA-O,O 0 )], 1, where
CBDCA is cyclobutane-1,1-dicarboxylate, Fig. 1, is a
Pt2+ anticancer drug in wide clinical use [1]. Using 2D
[1H,15N] heteronuclear single quantum coherence (HSQC)
NMR, 1D 13C and 1H NMR, and UV–visible spectroscopy, we showed that carboplatin reacts with carbonate
ion, present in culture media, blood and the cytosol, to produce carbonato carboplatin, cis-[Pt(NH3)2(O-CBDCA)(CO3)]2, and other carbonato complexes [2,3]. In vitro
cytotoxicity studies showed that the carbonato complexes
are more toxic to human neuroblastoma (SK-N-SH), renal
proximal tubule (HK-2) and Namalwa-luc Burkitt’s lymphoma cells than is intact 1, suggesting that small amounts
of carbonato complexes could form in therapy and be the
species responsible for the antitumor eﬀects of carboplatin
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[3]. Earlier we also showed that carbonate reacts with the
related drug, cisplatin, and that one of the complexes is
selectively modiﬁed by Jurkat cells, immortalized T lymphocytes, using an extra-cellular mechanism [4,5].
We here use [1H,15N] HSQC NMR and 15N-labeled 1 to
show that the rate of disappearance of carboplatin in the
medium is aﬀected not only by substances present in the
culture medium but also by an unknown substance(s)
released by the cells to the medium. As with previously
reported experiments with cisplatin [4], no HSQC NMR
active product peaks are observed in the NMR experiment
with carboplatin and Jurkat cells. Since Jurkat cells take up
only a small fraction of the total amount of platinum present in the medium [3], the disappearance of 1 cannot be due
to simple absorption of the compound by the cells. We also
demonstrate that the results of the cell/NMR experiments
are independent of the nature of the atmosphere above
the cells. Rate constants for the disappearance of 1 in the
presence of Jurkat cells in a static atmosphere (closed
NMR tube) ﬁt well (R2 = 0.96) with the previously
reported rate constant for the disappearance of carboplatin
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Fig. 1. Structure of carboplatin.

in the presence of 4.5 · 107 cells mL1 kept under standard
conditions in a humidiﬁed, 5% CO2 atmosphere in a incubator [2].
2. Materials and methods

3. Results and discussion

Fig. 2. [1H,15N] HSQC NMR spectrum of 110 lM 15N-carboplatin in
culture medium (RPMI + 10% FBS, 100 lg/mL streptomycin, 100 IU/mL
penicillin, and 2.0 mM S-glutamine) containing 2.7 · 107 Jurkat cells
mL1, pH = 7.4, 9.6 h after the addition of carboplatin to the medium
containing the cells.

Table 1
Pseudo-ﬁrst order decay constant, k1, for the disappearance of carboplatin
in culture medium containing Jurkat cells determined using [1H,15N]
HSQC NMR
Jurkat cell density (cells mL1)

k1 (s1)

2.7 · 107
8.2 · 107
21.2 · 107
27.2 · 107

2.28 ± 0.60 · 106
7.36 ± 1.02 · 106
13.41 ± 2.94 · 106
15.41 ± 1.67 · 106

1.6E-05

observed rate constant, s-1

K2PtCl4, H2CBDCA, 15NH4Cl and D2O (99.9%) were
purchased from Sigma–Aldrich (St. Louis, MO). Fetal
bovine serum (FBS) and RPMI-1640 (15–040) were purchased from Mediatech (Herndon, VA). 15N-labeled carboplatin was prepared as previously described [2]. [1H,15N]
HSQC NMR spectra were recorded on a Bruker Avance
500 MHz NMR equipped with a 5 mm triple axis probe
in the earlier described manner [5]. Peak volumes in arbitrary units, excluding 195Pt satellites, were calculated using
Bruker software. Each kinetic run consisted of ten successive NMR measurements (each 60 min in length, ns = 48)
for a total duration of 10 h. The 15N chemical shift of 1
was referenced externally to 1 M (15NH4)2SO4 in 5% D2O
which was acidiﬁed to pH 1 by the addition of H2SO4.
The 1H chemical shift of 1 was referenced externally to 3trimethylsilyl propionic acid-d4 sodium salt (TSP) in a
pH 7.15, 23 mM sodium carbonate buﬀer. Freshly prepared labeled carboplatin in water was added to culture
medium (RPMI + 10% FBS, 100 lg/mL streptomycin,
100 IU/mL penicillin, and 2.0 mM S-glutamine) containing
either 2.7, 8.2, 21.2 or 27.2 · 107 Jurkat cells per mL, in a
ﬁnal volume of 920 ll, and spectra were recorded in 5%
D2O at 37 C. Jurkat cells used were 97% viable, measured by light microscopy, using a hemacytometer under
standard trypan blue conditions [6].

1.2E-05

8.0E-06

4.0E-06

0.0E+00

As is shown in Fig. 2, 15N-labeled carboplatin exhibits a
single HSQC NMR peak due to the two symmetry-equivalent ammonia molecules. The pseudo-ﬁrst order decay constant, k1, for the disappearance of carboplatin in culture
medium containing Jurkat cells was determined by ﬁtting
a plot of carboplatin concentration (calculated from the
HSQC NMR peak intensity) versus time to a line and
dividing the slope of the linear ﬁt by its y-intercept. The
values obtained for k1 are given in Table 1, with statistical
errors from the linear ﬁts, and are plotted versus cell den-
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Fig. 3. Observed rate constant of the disappearance of carboplatin
obtained from HSQC NMR as a function of number of cells per mL.
Open diamonds are k1 values already reported by us [2]. The best ﬁt line,
R2 = 0.96, is k1 = (1.94 · 106 + 5.14 · 1014 mL cell1N) s1, so that
ku = 5.14 · 1014 mL cell1 s1.

sity in Fig. 3. Also plotted in Fig. 3 are the previously
reported k1 values for the disappearance of carboplatin in
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culture medium (no cells) and in culture medium containing 4.5 · 107 cells mL1 kept under standard conditions
in a humidiﬁed 5% CO2 atmosphere in an incubator [2].
In the previously described cell experiment [2], aliquots of
cells plus medium were removed from the culture ﬂask,
cells were separated from the medium by centrifugation,
5% D2O was added to the medium and NMR data was collected for 0.5 h. As can be seen in Fig. 3, all the data points
are consistent with the best ﬁt (R2 = 0.96) line k1s = 1.94 ·
106 + 5.14 · 1014 (mL cell1)N, demonstrating that cell
studies will yield the same results regardless if the reaction
with drug is done in a 5 mm capped NMR tube or in a
humidiﬁed, 5% CO2 incubator.
A striking feature of the reaction of 1 in these studies is
that no new HSQC NMR peaks associated with products
are observed. As we, as well as Sadler and coworkers, have
shown [2,7–9], reaction of 1 with nucleophiles lifts the
equivalency of the two ammonia molecules to produce
new peaks, the positions of which are sensitive to the nature of the ligands trans to the ammonia molecules. Sulfur
in the form of a thiol (cysteine) or thioether (methionine)
is the most potent nucleophile for Pt2+ present in culture
media. While a sulfur ligand trans to an ammonia molecule
would make the latter vulnerable to a substitution reaction
due to the trans eﬀect, these complexes, with N trans to S,
are suﬃciently stable to be easily detected at 40 ppm
(N) using HSQC NMR [4,7–11]. No products of this type
or of any other species were observed in the reaction.
The prospect that the disappearance of the HSQC NMR
peak for 1 in the presence of cells is due to absorption of
carboplatin by the cells is highly unlikely. As we earlier
showed, Jurkat cells under conditions similar to those used
here remove platinum species from solution at a rate which
is only 16.6 ± 4.2 · 1018 mol Pt h1 cell1 [3]. This rate of
platinum removal by cells is too slow to show an observable eﬀect on the total pool of 1 in the medium above the
cells during the time course of these experiments.
In the presence of culture medium without cells, the concentration of carboplatin [1] should obey
d½1
¼ k c ½1½CO2
3   k m ½1
dt
where kc is the rate constant for reaction of 1 with carbonate in the medium, a second order process, which behaves
like a pseudo-ﬁrst order reaction because [CO2
3 ] is
constant under the reaction conditions used [2]. The quantity km is the rate constant for reaction of 1 with other
substances in the medium, which is assumed to be a ﬁrst order process. For example, earlier studies showed that FBS,
a suite of proteins needed for cell growth, is also a signiﬁcant factor causing the disappearance of 1 in culture media
[2].
If cells, or some substance released by them, can modify
carboplatin so that it does not give an NMR signal, a term
ku[1]N should be added to the equation for d[1]/dt, where
N is the density of cells in the medium. The solution to the
resulting equation is an exponential decay,

½1 ¼ ½10 expfðk c ½CO2
3  þ k m þ k u N Þtg ¼ ½10 expfk 1 tg
where the eﬀective decay constant k 1 ¼ k c ½CO2
3  þ kmþ
k u N . The observed values of k1, shown in Fig. 3, depend
linearly on cell density. The y-intercept, 1.94 ± 0.76 ·
106 s1 represents k c ½CO2
3  þ k m ; from the slope, we obtain ku = 5.14 ± 0.52 · 1014 mL cell1 s1. When the density of cells is P8.2 · 107 cells mL1, the reaction of
carboplatin with cells is more important than reaction of
drug with carbonate or other substances in the culture
medium. Since, as noted, direct removal of 1 by cells is
unimportant, the reaction must involve a substance released by the cells.
Earlier studies by us using cisplatin [4,5] showed that
Jurkat cells can rapidly modify the mono-carbonato complex, cis-[Pt(NH3)2(CO3)Cl], converting it into a substance that is not capable of binding to the cells and is
undetectable using HSQC NMR. Moreover, the amount
of modiﬁcation of the mono-carbonato complex is dependent on the number of cells and recent studies by our group
(Centerwall et al., personal communication) show that the
platinum-modifying substance is released to the culture
medium above the cells. Unlike the relatively slow decay
rate observed for carboplatin in the presence of cells in
these experiments, the rate of modiﬁcation of the cisplatin
mono-carbonato complex by Jurkat cells is extremely
rapid, occurring within 0.6 h of the addition of drug to
the culture medium above the cells [4,5]. It seems likely that
both drugs are exposed to the same cell-released modifying
substance, but since carboplatin has a bidentate chelate
ring which blocks nucleophiles from attacking the axial
sites of the compound, it is much less susceptible to chemical modiﬁcation than is the cisplatin mono-carbonato species. Clearly, additional work is needed to determine the
nature of the species released by the cells and products
formed in the reaction.
4. Conclusion
Jurkat cells release a substance to the culture medium
that reacts with carboplatin, converting it into a substance
that, under the conditions of the experiment, is not
detectable using HSQC NMR. This disappearance from
HSQC NMR is identical to that observed for a mono-carbonato complex of cisplatin except that, due to structural
diﬀerences between cisplatin and carboplatin, the rate of
reaction with carboplatin is much slower than with
cisplatin.
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